These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 25131336)

  • 21. Articular status of haemophilia patients with inhibitors.
    Morfini M
    Haemophilia; 2008 Nov; 14 Suppl 6():20-2. PubMed ID: 19134029
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Home treatment of haemophilia patients with inhibitors.
    Oyesiku JO
    Haemophilia; 2011 Mar; 17(2):173-8. PubMed ID: 21070497
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clot lysis phenotype and response to recombinant factor VIIa in plasma of haemophilia A inhibitor patients.
    Bakhtiari K; Kamphuisen PW; Mancuso ME; Hamulyak K; Schutgens RE; Santagostino E; Meijers JC
    Br J Haematol; 2013 Sep; 162(6):827-35. PubMed ID: 23889493
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Outpatient diagnostic of bladder tumours in flexible cystoscopes: evaluation of fluorescence-guided flexible cystoscopy and bladder biopsies.
    Hermann GG; Mogensen K; Toft BG; Glenthøj A; Pedersen HM
    Scand J Urol Nephrol; 2012 Feb; 46(1):31-6. PubMed ID: 22150596
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Milestones in hemophilia and concepts in future clinical trial design.
    Lusher JM
    Semin Hematol; 2006 Jan; 43(1 Suppl 1):S84-7. PubMed ID: 16427391
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Allergenic vaccines administration and inhibitor development in haemophilia.
    Bermejo N; Martín Aguilera C; Carnicero F; Bergua J
    Haemophilia; 2012 Sep; 18(5):e392-3. PubMed ID: 22672147
    [No Abstract]   [Full Text] [Related]  

  • 27. The benefits of prophylactic treatment with APCC in patients with haemophilia and high-titre inhibitors: a retrospective case series.
    Valentino LA
    Haemophilia; 2009 May; 15(3):733-42. PubMed ID: 19298380
    [TBL] [Abstract][Full Text] [Related]  

  • 28. ESOS: a European study on the orthopaedic status of patients with haemophilia and inhibitors.
    Dolan G
    Haemophilia; 2005 Nov; 11 Suppl 1():24-5. PubMed ID: 16219046
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Successful low dose immune tolerance induction in severe haemophilia A with inhibitors below 40 Bethesda Units.
    Ter Avest PC; Fischer K; Gouw SC; Van Dijk K; Mauser-Bunschoten EP
    Haemophilia; 2010 May; 16(102):71-9. PubMed ID: 20536988
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Safety and efficacy of recombinant activated factor VII for long-term secondary prophylaxis in a haemophilia boy with high-titre inhibitors.
    Chuansumrit A; Sirachainan N; Panuwannakorn M; Wongwerawattanakoon P; Kadegasem P; Choeyprasert W; Sasanakul W
    Haemophilia; 2013 May; 19(3):e182-3. PubMed ID: 23600908
    [No Abstract]   [Full Text] [Related]  

  • 31. Frequency of factor VIII (FVIII) inhibitor in haemophilia A.
    Borhany M; Kumari M; Shamsi T; Naz A; Farzana T
    J Coll Physicians Surg Pak; 2012 May; 22(5):289-93. PubMed ID: 22538032
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Plasma exchange and immunosuppressive therapy in a case of mild haemophilia A with inhibitors and a life-threatening lower limb haemorrhage.
    Ambaglio C; Lodo F; Trinchero A; Ghidelli N; Perotti C; Del Fante C; Gamba G
    Blood Transfus; 2014 Jan; 12(1):119-23. PubMed ID: 24553597
    [No Abstract]   [Full Text] [Related]  

  • 33. Extensive bleeding due to an inhibitor in a haemophilia A patient with a Tyr2105Cys mutation: elimination of the inhibitor with rituximab.
    Williams VK; Pham C; Suppiah R
    Pathology; 2015 Oct; 47(6):586-8. PubMed ID: 26308136
    [No Abstract]   [Full Text] [Related]  

  • 34. Protective effect of prophylaxis on inhibitor development in children with haemophilia A: more convincing studies are required.
    Calvez T; Laurian Y
    Br J Haematol; 2006 Mar; 132(6):798-800; author reply 800-1. PubMed ID: 16487187
    [No Abstract]   [Full Text] [Related]  

  • 35. Adult haemophilia A patients with inhibitors: successful immune tolerance induction with a single FVIII/VWF product.
    Rangarajan S; Jiménez-Yuste V; Santagostino E
    Haemophilia; 2014 Nov; 20(6):e414-7. PubMed ID: 25333452
    [No Abstract]   [Full Text] [Related]  

  • 36. Acquired haemophilia in a patient treated with interferon-α for hepatitis C infection.
    Goyal J; Tyagi P; Kumar N
    Haemophilia; 2012 May; 18(3):e73-4. PubMed ID: 22404644
    [No Abstract]   [Full Text] [Related]  

  • 37. Mycophenolate in the remission induction of a patient with acquired haemophilia A.
    Lee YS; Ng HJ
    Haemophilia; 2010 Jan; 16(1):180-2. PubMed ID: 19780847
    [No Abstract]   [Full Text] [Related]  

  • 38. A consensus statement on clinical trials of bypassing agent prophylaxis in inhibitor patients.
    Teitel J; Berntorp E; Dolan G; Fischer K; Gringeri A; Kessler C; Lambert T; Leissinger C; Nemes L; Shima M
    Haemophilia; 2011 May; 17(3):516-21. PubMed ID: 21371181
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Successful treatment of acquired haemophilia in a patient with bullous pemphigoid with single-dosing regimen of rituximab.
    Zhang X; Guo J; Guo X; Pan J
    Haemophilia; 2012 Sep; 18(5):e393-5. PubMed ID: 22823057
    [No Abstract]   [Full Text] [Related]  

  • 40. The Rodin (Research Of Determinants of INhibitor Development among PUPs with haemophilia) study: the clinical conundrum from the perspective of haemophilia treaters.
    Kessler CM; Iorio A
    Haemophilia; 2013 May; 19(3):351-4. PubMed ID: 23577743
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.